Home / Resource Library / Gut Bacterial Diversity Associates with Efficacy of Anti-CD19 CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma

Gut Bacterial Diversity Associates with Efficacy of Anti-CD19 CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma

ASH 2020: Study examined the association of gut bacteria diversity and effectiveness of CAR T therapy in patients with large cell lymphoma.